Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when OXSQ files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: OXSQ Oxford Square Capital Corp. 8-K

Oxford Square Capital amends at-the-market equity program to continue share sales

Filed May 6, 2026 · Period ending May 5, 2026 · ~1 min read

3 key changes 2 sections

Key Changes

  • medium

    Oxford Square amended its equity distribution agreement with sales agents to continue selling common stock under its current shelf registration statement (No. 333-290511). This at-the-market program allows the company to raise capital by gradually selling shares into the market.

  • medium

    The amendment updates the original agreement from August 2024 and is supported by a prospectus supplement dated May 5, 2026. Sales agents include Lucid Capital Markets and Ladenburg Thalmann.

  • low

    Dechert LLP provided a legal opinion confirming the validity of shares to be sold under the amended agreement, a standard requirement for securities offerings.

Summary

Oxford Square Capital Corp., a business development company, has amended its at-the-market equity distribution agreement to continue selling common stock under its existing shelf registration. This amendment updates the original August 2024 agreement and allows the company to raise capital by selling shares gradually through designated broker-dealers rather than through traditional underwritten offerings. For holders of OXSQH (preferred shares), this matters because additional common stock sales will dilute existing equity holders and may impact the company's capital structure.

The company is using its effective Form N-2 shelf registration (No. 333-290511) with a new prospectus supplement dated May 5, 2026. Watch for subsequent 8-K filings or quarterly reports that disclose the actual amount of shares sold and proceeds raised under this amended program, as this will indicate how aggressively management is using this capital-raising tool and whether the company faces funding pressures.

Section-by-Section Diff

Event · Item 1.01 — Entry into a Material Definitive Agreement

~300 words

Item 1.01 — Entry into a Material Definitive Agreement filed; see Key Changes for terms.

1 Added
Added Shelf registration statement reference medium

Added in current filing · verify on EDGAR →

The offering is being made pursuant to the Company’s effective shelf registration statement on Form N-2 (Registration No. 333-290511) filed with the Securities and Exchange Commission, as supplemented by a prospectus supplement, dated May 5, 2026.

The company is using its effective shelf registration statement (Registration No. 333-290511) filed on Form N-2, with a prospectus supplement dated May 5, 2026. This registration framework allows the company to offer and sell securities on an ongoing basis without filing a new registration for each offering.

Event · Item 9.01 — Financial Statements and Exhibits

~100 words

Item 9.01 — Financial Statements and Exhibits filed; see Key Changes for terms.

1 Added
Added Equity Distribution Agreement Amendment medium

Added in current filing · verify on EDGAR →

Amendment No. 1 to the Amended and Restated Equity Distribution Agreement, dated as of May 5, 2026, by and among Oxford Square Capital Corp., Oxford Square Management, LLC, Oxford Funds, LLC, Lucid Capital Markets, LLC and Ladenburg Thalmann & Co. Inc., as sales agents.

The company amended its equity distribution agreement with multiple sales agents on May 5, 2026. This type of agreement typically governs at-the-market equity offerings, allowing the company to sell shares through designated broker-dealers. The specific terms of the amendment are not disclosed in this 8-K filing.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify